Comerica Bank Uni Qure N.V. Transaction History

Comerica Bank

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$18.12 - $27.32 $128,380 - $193,562	-7,085 Reduced 23.83%	22,646 $0
Q3 2022 Oct 28, 2022	BUY	$16.98 - $25.54 $10,527 - $15,834	620 Added 2.13%	29,731 $549,000
Q2 2022 Aug 02, 2022	BUY	$13.15 - $20.45 $9,468 - $14,724	720 Added 2.54%	29,111 $701,000
Q1 2022 Apr 27, 2022	SELL	$14.54 - $21.5 $4,580 - $6,772	-315 Reduced 1.1%	28,391 $513,000
Q4 2021 Feb 18, 2022	SELL	$20.24 - $36.01 $45,722 - $81,346	-2,259 Reduced 7.3%	28,706 $595,000
Q3 2021 Nov 22, 2021	BUY	$26.01 - $38.22 $805,399 - $1.18 Million	30,965 New	30,965 $991,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

Stay updated on Comerica Bank with notifications on news.